Image Place holder

Lucia Seminario-Vidal, MD, PhD

Specialty: Dermatology
Program: Cutaneous Oncology

Call 1-888-MOFFITT

Call 1-888-MOFFITT


Cancer Focus: Basal Cell Carcinoma , Cutaneous Lymphoma (CTCL), Melanoma , Skin Cancer (Nonmelanoma)

Dr. Lucia Seminario-Vidal is a board-certified dermatologist in the Department of Cutaneous Oncology at Moffitt and an assistant professor in the University of South Florida (USF) Department of Dermatology. She is the associate director of dermatology clinical research, and the director of the dermatology consult service providing inpatient dermatology services at Moffitt. Dr. Seminario specializes in general and complex dermatology, with a special interest in cutaneous lymphomas, drug eruptions, cutaneous diseases in immunocompromised patients, and skin cancers. Dr. Seminario is also the lead dermatologist of the multidisciplinary cutaneous lymphoma clinic at Moffitt. In this multidisciplinary clinic, each patient’s care plan is reviewed by a highly expert team of physicians with extensive, focused training in their area of specialty, giving them additional insights and knowledge to help make the best treatment decisions. Dr. Seminario enjoys working with medical students and residents in clinic as well as in scholarly activities and research projects. During her career, she has received numerous awards related to her clinical and research endeavors. She is widely published, and has presented her work at diverse local, regional, national, and international meetings. She has developed investigator initiated studies and has participated in more than 30 clinical trials. She is a fellow of the American Academy of Dermatology, and an active member of the International Cutaneous Lymphoma Society, the United States Cutaneous Lymphoma Society, and the Society of Investigative Dermatology. She participates in national committees, including the scientific committee of the Society of Dermatology Hospitalists and the external grants committee of the Women Dermatologic Society.

Education & Training

Board Certification:

  • Dermatology


  • University of Alabama Birmingham - Clinical Trials


  • University of Alabama Birmingham - Dermatology

Medical School:

  • Universidad Peruana Cayetano Heredia Medical School(MD, - MD)
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Malachowski SJ, Hatch LA, Sokol L, Messina J, Seminario-Vidal L. Pembrolizumab-associated tumor development in a patient with Sézary syndrome. JAAD Case Rep. 2020 Jan.6(1):16-18. Pubmedid: 31909130. Pmcid: PMC6938917.
  • Haynes D, Hammer P, Malachowski SJ, Kaffenberger B, Yi JS, Vera N, Calhoun C, Shinohara MM, Seminario-Vidal L, Trinidad JC, Keller JJ, Ortega-Loayza AG. Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi-centre study. Int Wound J. 2019 Sep.16(6):1440-1444. Pubmedid: 31475449.
  • Moy A, Sun J, Ma S, Seminario-Vidal L. Lymphomatoid Papulosis and Other Lymphoma-Like Diseases. Dermatol Clin. 2019 Oct.37(4):471-482. Pubmedid: 31466587.
  • Malachowski SJ, Sun J, Chen PL, Seminario-Vidal L. Diagnosis and Management of Cutaneous B-Cell Lymphomas. Dermatol Clin. 2019 Oct.37(4):443-454. Pubmedid: 31466585.
  • Ayoubi N, Haque A, Vera N, Ma S, Messina J, Khushalani N, Seminario-Vidal L. Ipilimumab/nivolumab-induced pseudolymphoma in a patient with malignant melanoma. J Cutan Pathol. 2019 Nov.47(4):390-393. Pubmedid: 31677178.
  • Metterle L, Hatch L, Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature. Pediatr Dermatol. 2019 Nov.37(1):124-129. Pubmedid: 31691347.
  • Weinkle A, Kaffenberger BH, Trinidad JC, Ergen EN, Keller J, Seminario-Vidal L. Reply to: "Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review". J Am Acad Dermatol. 2019 Nov.82(3):e113. Pubmedid: 31712175.
  • Le NK, Billington A, Harrington M, Seminario-Vidal L. Management of Recessive Dystrophic Epidermolysis Bullosa in a Newborn with Porcine-derived Extracellular Matrix. Plast Reconstr Surg Glob Open. 2019 Nov.7(11):e2519. Pubmedid: 31942309. Pmcid: PMC6908358.
  • Weinkle A, Pettit C, Jani A, Keller J, Lu Y, Malachowski S, Trinidad JC, Kaffenberger BH, Ergen EN, Hughey LC, Smith D, Seminario-Vidal L. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review. J Am Acad Dermatol. 2019 May.81(3):749-757. Pubmedid: 31150704.
  • Lilly E, Bunick CG, Maley AM, Zhang S, Spraker MK, Theos AJ, Vivar KL, Seminario-Vidal L, Bennett AE, Sidbury R, Ogawa Y, Akiyama M, Binder B, Hadj-Rabia S, Morotti RA, Glusac EJ, Choate KA, Richard G, Milstone LM. More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations. J Am Acad Dermatol. 2019 Mar.80(3):617-625. Pubmedid: 30287322. Pmcid: PMC6372339.
  • Cohen L, Seminario-Vidal L, Lockey RF. Dermatologic Problems Commonly Seen by the Allergist/Immunologist. J Allergy Clin Immunol Pract. 2019 Jul.8(1):102-112. Pubmedid: 31351991.
  • Hatch LA, Laurain D, Messina J, Seminario-Vidal L. An erythematous facial rash. J Fam Practice. 2019 Dec.68(10):E9-E11. Pubmedid: 31860705.
  • Cohen L, Chen PL, Zhang L, Sokol L, Seminario-Vidal L. Skin-first nodulotumoral adult T-cell lymphoma mimicking cutaneous T-cell lymphoma. JAAD Case Rep. 2019 Aug.5(8):650-652. Pubmedid: 31388529. Pmcid: PMC6677771.
  • Cohen L, Haque A, Ma S, Zhang L, Sokol L, Seminario-Vidal L. T-cell prolymphocytic leukemia presenting with erythematous patches, plaques, and erythema gyratum-like lesions masquerading as Sézary syndrome. JAAD Case Rep. 2019 Aug.5(8):686-690. Pubmedid: 31440557. Pmcid: PMC6698441.
  • Hatch LA, Ma S, Seminario-Vidal L. Purpuric ecchymoses in the elderly: senile purpura or hematologic malignancy? A case of blastic plasmacytoid dendritic cell neoplasm. Int J Dermatol. 2019 Aug. Pubmedid: 31468501.
  • Gutierrez EL, Ramos W, Seminario-Vidal L, Tello M, Ronceros G, Ortega-Loayza AG. Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies. An Bras Dermatol. 2018 Mar.93(2):212-215. Pubmedid: 29723379. Pmcid: PMC5916392.
  • Castillo B, Vera N, Ortega-Loayza AG, Seminario-Vidal L. Wound care for Stevens-Johnson Syndrome and toxic epidermal necrolysis; A Systematic Review. J Am Acad Dermatol. 2018 Mar. Pubmedid: 29601936.
  • He Y, Seminario-Vidal L, McLeod HL. Avoidance of Severe Cutaneous Adverse Drug Events as a First Step in Precision Neurology. JAMA Neurol. 2018 Jul;75(7):793-795. Pubmedid: 29610896.
  • Vivar KL, Mancl K, Seminario-Vidal L. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide. Clin Case Rep. 2018 Feb.6(2):258-261. Pubmedid: 29445458. Pmcid: PMC5799627.
  • Choi H, Castillo B, Seminario-Vidal L. Silver absorption in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with silver-impregnated dressings. A case series. Int Wound J. 2018 Dec.15(6):1049-1051. Pubmedid: 29893032.
  • Castillo B, Gibbs J, Brohl AS, Seminario-Vidal L. Checkpoint inhibitor-associated cutaneous small vessel vasculitis. JAAD Case Rep. 2018 Aug.4(7):675-677. Pubmedid: 30112452. Pmcid: PMC6092526.
  • Vera N, Patel NU, Seminario-Vidal L. Rosacea Comorbidities. Dermatol Clin. 2018 Apr;36(2):115-122. Pubmedid: 29499794.
  • Nethers K, Messina J, Seminario-Vidal L. Eccrine squamous syringometaplasia in an allogenic stem cell transplant patient undergoing chemotherapy. Dermatol Online J. 2017 Sep;23(9). Pubmedid: 29469718.
  • Laurain D, Seminario-Vidal L, Rodriguez-Waitkus P, Shenefelt P. Tense Bullae on the Penile Shaft: Challenge. Am J Dermatopathxxx. 2017 Nov;39(11):e156-e157. Pubmedid: 29053552.
  • Laurain D, Seminario-Vidal L, Rodriguez-Waitkus P, Shenefelt P. Tense Bullae on the Penile Shaft: Answer. Am J Dermatopathxxx. 2017 Nov;39(11):870. Pubmedid: 29053549.
  • Oak AS, Seminario-Vidal L, Sami N. Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatol Ther. 2017 Mar;30(2). Pubmedid: 27860166.
  • Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, Harrington MA, Seminario-Vidal L. Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy. J Cutan Pathol. 2017 Apr;44(4):381-384. Pubmedid: 28000240.
  • Seminario-Vidal L, Kole L, Knapp C, Fort P, Kankirawatana S, Atkinson TP, McKay KM, Theos A. Dermatological clues to the diagnosis of atypical complete DiGeorge syndrome. Dermatol Online J. 2016 Nov;22(11). Pubmedid: 28329565.
  • Weinkle AP, Patel N, Kissel R, Seminario-Vidal L. Acquired acrodermatitis enteropathica as a presenting sign of celiac disease. JAAD Case Rep. 2016 May;2(3):193-195. Pubmedid: 27222886. Pmcid: PMC4873608.
  • Makeeva V, Seminario-Vidal L, Beckum K, Sami N. Bilateral periorbital swelling as the initial presentation of cutaneous lupus erythematosus. JAAD Case Rep. 2016 Jan;2(1):72-76. Pubmedid: 27051834. Pmcid: PMC4809478.
  • Seminario-Vidal L, Jensen JD, Fening K, McKay K, Elmets C, Theos A. Long-Standing Spicules in a Patient with Acute Lymphoblastic Leukemia. Pediatr Dermatol. 2016 Apr;32(4):545-546. Pubmedid: 25691258.
  • Seminario-Vidal L, Guerrero C, Sami N. Refractory Sweet's syndrome successfully treated with rituximab. JAAD Case Rep. 2015 May;1(3):123-125. Pubmedid: 27051705. Pmcid: PMC4808708.
  • Pavlidakey PG, Seminario-Vidal L, McKay KM, Sami N. Spirochete immunostaining is not just for syphilis: diagnostic utility in borreliosis. J Cutan Pathol. 2015 May;42(5):370-372. Pubmedid: 25918979.
  • Seminario-Vidal L, Hughey LS. Hydroxychloroquine de Novo-Induced Psoriasis in a Patient With Lichen Planus Pigmentosus. Skinmed. 2015 Dec.13(6):492-494. Pubmedid: 26861533.
  • Seminario-Vidal L, Sami N, Miller J, Theos A. Mycophenolate mofetil therapy for pediatric bullous pemphigoid. Dermatol Online J. 2015 Aug;21(8). Pubmedid: 26437160.
  • Seminario-Vidal L, Cantrell W, Elewski BE. Pulmonary Cryptococcosis in the Setting of Tofacitinib Therapy for Psoriasis. J Drugs Dermatol. 2015 Aug;14(8):901-902. Pubmedid: 26267737.
  • Hunt KM, Kissel R, Seminario-Vidal L. Progressive widespread cutaneous telangiectasias. JAMA Dermatol. 2014 Oct;150(10):1103-1104. Pubmedid: 25142837.
  • Okada SF, Ribeiro CM, Sesma JI, Seminario-Vidal L, Abdullah LH, van Heusden C, Lazarowski ER, Boucher RC. Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. Am J Respir Cell Mol Biol. 2013 Nov;49(5):814-820. Pubmedid: 23763446. Pmcid: PMC3931099.
  • Seminario-Vidal L, van Heusden C, Mugesh G, Lazarowski ER. Erratum to: Ebselen is a potent non-competitive inhibitor of extracellular nucleoside diphosphokinase. Purinergic Signal. 2011 Jun;7(2):277. Pubmedid: 21494852. Pmcid: PMC3146640.
  • Seminario-Vidal L, Okada SF, Sesma JI, Kreda SM, van Heusden CA, Zhu Y, Jones LC, O'Neal WK, Penuela S, Laird DW, Boucher RC, Lazarowski ER. Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia. J Biol Chem. 2011 Jul;286(30):26277-26286. Pubmedid: 21606493. Pmcid: PMC3143590.
  • Lazarowski ER, Sesma JI, Seminario-Vidal L, Kreda SM. Molecular mechanisms of purine and pyrimidine nucleotide release. Adv Pharmacol. 2011 Aug;61:221-261. Pubmedid: 21586361.
  • Kreda SM, Seminario-Vidal L, van Heusden CA, O'Neal W, Jones L, Boucher RC, Lazarowski ER. Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol. 2010 Jun;588(Pt 12):2255-2267. Pubmedid: 20421285. Pmcid: PMC2911224.
  • Seminario-Vidal L, Kreda S, Jones L, O'Neal W, Trejo J, Boucher RC, Lazarowski ER. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways. J Biol Chem. 2009 Jul;284(31):20638-20648. Pubmedid: 19439413. Pmcid: PMC2742828.
  • Seminario-Vidal L, Lazarowski ER, Okada SF. Assessment of extracellular ATP concentrations. Methods Mol Biol. 2009 Dec;574:25-36. Pubmedid: 19685297.
  • Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, Anderson JM. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol. 2006 Dec;291(6):F1288-F1299. Pubmedid: 16804102.